secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2026-06-04T20:10:06+00:00
Accession:  0001193125-26-257400
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tenax Therapeutics reports results of 2026 annual shareholder meeting
---------------------------------------------------------------------

- Stockholders elected seven directors: June Almenoff (17.36M for), Michael Davidson (15.76M), Declan Doogan, Christopher T. Giordano, Robyn M. Hunter, Gerald T. Proehl, Stuart Rich.
- Auditor Cherry Bekaert LLP ratified with 21.30M for, 3,688 against, 11,073 abstain, no broker non-votes.
- All director nominees received over 17.3 million votes in favor except Michael Davidson with 15.76 million.
- The meeting was held on June 2, 2026; results filed June 4, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000119312526257400/0001193125-26-257400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000119312526257400/d69762d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-257400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer